Biotech firm sets up HK office (hktdc.com)


	InvestHK's Charles Ng and Dr Thomas Schweins, Vice-president, Marketing and Strategy, QIAGEN

QIAGEN N.V., a multinational biotechnology company headquartered in Germany, has announced the opening of its office in Hong Kong, following ten years experience in the city working with local partners and distributors.

"QIAGEN's new subsidiary in Hong Kong has been established in response to the fast developing biomedical research community here. This underlines our commitment to Hong Kong as an important hub for life science and healthcare," said Dr. Frauke Ehlert, General Manager of QIAGEN China and Hong Kong.

The opening marks a substantial expansion for QIAGEN, allowing the company to better serve its local and regional customers as well as developing stronger collaboration with Hong Kong's biotechnology community. QIAGEN's Hong Kong office will also manage the distribution of products manufactured in the Chinese mainland to various parts of the world.

"We are building a team and infrastructure to support scientists and physicians in local universities and hospitals to discover disease mechanisms and develop cures for them," Dr. Ehlert said.

QIAGEN N.V. is the leading provider of biomedical research and molecular diagnostics technologies and products. The company's products are sold to academic research markets, pharmaceutical and biotechnology companies, applied testing customers and molecular diagnostics laboratories. QIAGEN employs more than 3,000 people worldwide and its products are sold through 22 subsidiaries and a network of distributors in more than 40 countries. Source: InvestHK